Valley National Advisers’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17
Closed -$4K 1017
2022
Q3
$4K Sell
17
-23
-58% -$6.21K ﹤0.01% 721
2022
Q2
$11K Buy
40
+2
+5% +$540 ﹤0.01% 562
2022
Q1
$13K Buy
38
+10
+36% +$3.08K ﹤0.01% 566
2021
Q4
$10K Sell
28
-5
-15% -$1.69K ﹤0.01% 612
2021
Q3
$11K Buy
33
+3
+10% +$1.02K ﹤0.01% 571
2021
Q2
$9K Buy
30
+6
+25% +$1.84K ﹤0.01% 601
2021
Q1
$8K Buy
24
+7
+41% +$2.24K ﹤0.01% 579
2020
Q4
$6K Hold
17
﹤0.01% 596
2020
Q3
$5K Hold
17
﹤0.01% 575
2020
Q2
$4K Hold
17
﹤0.01% 604
2020
Q1
$2K Hold
17
﹤0.01% 659
2019
Q4
$3K Hold
17
﹤0.01% 668
2019
Q3
$0 Hold
17
﹤0.01% 839
2019
Q2
$4K Hold
17
﹤0.01% 588
2019
Q1
$0 Hold
17
﹤0.01% 836
2018
Q4
$6K Hold
17
﹤0.01% 514
2018
Q3
$0 Hold
17
﹤0.01% 764
2018
Q2
$0 Buy
+17
New +$6.16K ﹤0.01% 724

Other funds holding ABMD

Valley National Advisers's ABMD Position: Q4 2022 in Review

Valley National Advisers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 17 shares — an estimated $4K sold.

Valley National Advisers first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $13K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Valley National Advisers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Valley National Advisers sold 17 Abiomed Inc shares in Q4 2022, an estimated $4K.
  • Valley National Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Valley National Advisers's Abiomed Inc position peaked at $13K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Valley National Advisers's 13F filing for Q4 2022, filed 12 Jan 2023.